BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND KIF5B, ENSG00000170759, 3799, P33176, UKHC, KNS1, KNS, KINH
22 results:

  • 1. Polyautoimmunity in Patients With Anticyclic Citrullinated Peptide Antibody-Positive and -Negative Rheumatoid Arthritis: a Nationwide Cohort Study From Denmark.
    Kristensen S; Hagelskjær AM; Cordtz R; Bliddal S; Mortensen AS; Nielsen CH; Feldt-Rasmussen U; Lauridsen KB; Dreyer L
    J Rheumatol; 2024 Apr; 51(4):350-359. PubMed ID: 38302173
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial.
    Subbiah V; Cassier PA; Siena S; Garralda E; Paz-Ares L; Garrido P; Nadal E; Vuky J; Lopes G; Kalemkerian GP; Bowles DW; Seetharam M; Chang J; Zhang H; Green J; Zalutskaya A; Schuler M; Fan Y; Curigliano G
    Nat Med; 2022 Aug; 28(8):1640-1645. PubMed ID: 35962206
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing.
    Shi M; Wang W; Zhang J; Li B; Lv D; Wang D; Wang S; Cheng D; Ma T
    Cancer Sci; 2022 Jan; 113(1):308-318. PubMed ID: 34710947
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinical Analysis of 2 170 Cases of thyroid-Associated Ophthalmopathy Involving Extraocular Muscles].
    Yang M; Du BX; Wang YJ; He WM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Series of RET Fusion Spitz Neoplasms With Plaque-Like Silhouette and Dyscohesive Nesting of Epithelioid Melanocytes.
    Kim D; Compres EV; Zhang B; Khan AU; Sunshine JC; Quan VL; Gerami P
    Am J Dermatopathol; 2021 Apr; 43(4):243-251. PubMed ID: 33742998
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
    Yang SR; Aypar U; Rosen EY; Mata DA; Benayed R; Mullaney K; Jayakumaran G; Zhang Y; Frosina D; Drilon A; Ladanyi M; Jungbluth AA; Rekhtman N; Hechtman JF
    Clin Cancer Res; 2021 Mar; 27(5):1316-1328. PubMed ID: 33272981
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Discovery of 4-methyl-N-(4-((4-methylpiperazin- 1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-oxy)benzamide as a potent inhibitor of RET and its gatekeeper mutant.
    Li X; Su J; Yang Y; Lian W; Deng Z; Yang Z; Chen G; Zhang B; Dong C; Liu X; Li L; Wang Z; Hu Z; Xu Q; Deng X
    Eur J Med Chem; 2020 Dec; 207():112755. PubMed ID: 32882611
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies.
    Solomon BJ; Tan L; Lin JJ; Wong SQ; Hollizeck S; Ebata K; Tuch BB; Yoda S; Gainor JF; Sequist LV; Oxnard GR; Gautschi O; Drilon A; Subbiah V; Khoo C; Zhu EY; Nguyen M; Henry D; Condroski KR; Kolakowski GR; Gomez E; Ballard J; Metcalf AT; Blake JF; Dawson SJ; Blosser W; Stancato LF; Brandhuber BJ; Andrews S; Robinson BG; Rothenberg SM
    J Thorac Oncol; 2020 Apr; 15(4):541-549. PubMed ID: 31988000
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. RET fusions in solid tumors.
    Li AY; McCusker MG; Russo A; Scilla KA; Gittens A; Arensmeyer K; Mehra R; Adamo V; Rolfo C
    Cancer Treat Rev; 2019 Dec; 81():101911. PubMed ID: 31715421
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Analysis of Cell-Free DNA from 32,989 Advanced cancers Reveals Novel Co-occurring Activating
    Rich TA; Reckamp KL; Chae YK; Doebele RC; Iams WT; Oh M; Raymond VM; Lanman RB; Riess JW; Stinchcombe TE; Subbiah V; Trevarthen DR; Fairclough S; Yen J; Gautschi O
    Clin Cancer Res; 2019 Oct; 25(19):5832-5842. PubMed ID: 31300450
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib.
    Terzyan SS; Shen T; Liu X; Huang Q; Teng P; Zhou M; Hilberg F; Cai J; Mooers BHM; Wu J
    J Biol Chem; 2019 Jul; 294(27):10428-10437. PubMed ID: 31118272
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Selective RET kinase inhibition for patients with RET-altered cancers.
    Subbiah V; Velcheti V; Tuch BB; Ebata K; Busaidy NL; Cabanillas ME; Wirth LJ; Stock S; Smith S; Lauriault V; Corsi-Travali S; Henry D; Burkard M; Hamor R; Bouhana K; Winski S; Wallace RD; Hartley D; Rhodes S; Reddy M; Brandhuber BJ; Andrews S; Rothenberg SM; Drilon A
    Ann Oncol; 2018 Aug; 29(8):1869-1876. PubMed ID: 29912274
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Drug resistance profiles of mutations in the RET kinase domain.
    Liu X; Shen T; Mooers BHM; Hilberg F; Wu J
    Br J Pharmacol; 2018 Sep; 175(17):3504-3515. PubMed ID: 29908090
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers.
    Roskoski R; Sadeghi-Nejad A
    Pharmacol Res; 2018 Feb; 128():1-17. PubMed ID: 29284153
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. kif5b/RET Rearrangement in a Carcinoma of the thyroid Gland: A Case Report of a Fatal Disease.
    Viola D; Giani C; Mazzeo S; Ugolini C; Ciampi R; Molinaro E; Agate L; Borrelli N; Chella A; Fontanini G; Basolo F; Elisei R
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3091-3096. PubMed ID: 28911147
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Antitumor Activity of RXDX-105 in Multiple cancer Types with
    Li GG; Somwar R; Joseph J; Smith RS; Hayashi T; Martin L; Franovic A; Schairer A; Martin E; Riely GJ; Harris J; Yan S; Wei G; Oliver JW; Patel R; Multani P; Ladanyi M; Drilon A
    Clin Cancer Res; 2017 Jun; 23(12):2981-2990. PubMed ID: 28011461
    [No Abstract]    [Full Text] [Related]  

  • 17.
    Kato S; Subbiah V; Marchlik E; Elkin SK; Carter JL; Kurzrock R
    Clin Cancer Res; 2017 Apr; 23(8):1988-1997. PubMed ID: 27683183
    [No Abstract]    [Full Text] [Related]  

  • 18. Papillary thyroid microcarcinoma co-exists with Hashimoto's thyroiditis: Is strain elastography still useful?
    Li Y; Wang Y; Wu Q; Hu B
    Ultrasonics; 2016 May; 68():127-33. PubMed ID: 26945905
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A mouse model of kif5b-RET fusion-dependent lung tumorigenesis.
    Saito M; Ishigame T; Tsuta K; Kumamoto K; Imai T; Kohno T
    Carcinogenesis; 2014 Nov; 35(11):2452-6. PubMed ID: 25064355
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. RET rearrangements in lung adenocarcinoma and radiation.
    Dacic S; Luvison A; Evdokimova V; Kelly L; Siegfried JM; Villaruz LC; Socinski MA; Nikiforov YE
    J Thorac Oncol; 2014 Jan; 9(1):118-20. PubMed ID: 24346100
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.